KFDA warns sudden death risk on ADHD drugs

Published: 2009-06-23 06:58:00

Updated: 2009-06-23 06:58:00

The Korea Food and Drug Administration has recently issued a caution to medical doctors and pharmacists about prescribing attention deficit hyperactivity disorder (ADHD) drugs, such as methylphenidate.

A new study suggests that children and teens who take stimulants like Ritalin for ADHD have ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK